Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

ClinicalTrials.gov ID: NCT00021359

Public ClinicalTrials.gov record NCT00021359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Dexamethasone and 13-cis-Retinoic Acid as First-Line Treatment for Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with dexamethasone may be an effective treatment for multiple myeloma. PURPOSE: Phase II trial to study the effectiveness of combining isotretinoin and dexamethasone in treating patients who have multiple myeloma.

Study identification

NCT ID
NCT00021359
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fox Chase Cancer Center
Other
Enrollment
17 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1999 (Type not available)
Primary completion
Jul 2000 (Actual)
Completion
Oct 2005 (Actual)
Last update posted
Jul 10, 2013

1999 – 2005

United States locations

U.S. sites
18
U.S. states
2
U.S. cities
18
Facility City State ZIP Site status
Hunterdon Regional Cancer Center Flemington New Jersey 08822 —
Kimball Medical Center Lakewood New Jersey 08701 —
South Jersey Regional Cancer Center Millville New Jersey 08332 —
Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly New Jersey 08060 —
Riverview Medical Center - Booker Cancer Center Red Bank New Jersey 07701 —
Community Medical Center Toms River New Jersey 08755 —
St. Francis Medical Center Trenton New Jersey 08629 —
Bon Secours-Holy Family Health System Altoona Pennsylvania 16602 —
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Pinnacle Health Hospitals Harrisburg Pennsylvania 17105-8700 —
Conemaugh Memorial Hospital Johnstown Pennsylvania 15905 —
Saint Mary Regional Center Langhorne Pennsylvania 19047 —
North Penn Hospital Lansdale Pennsylvania 19446-1200 —
Paoli Memorial Hospital Paoli Pennsylvania 19301-1792 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Pottstown Memorial Regional Cancer Center Pottstown Pennsylvania 19464 —
Reading Hospital and Medical Center Reading Pennsylvania 19612-6052 —
Southern Chester County Medical Center West Grove Pennsylvania 19390 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00021359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00021359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →